Results 141 to 150 of about 301,296 (304)

In-hospital mortality and associated factors among patients admitted with venous thromboembolism at selected public hospitals of Harar Town, Eastern Ethiopia

SAGE Open Medicine
Background: Venous thromboembolism is the third most common cause of cardiovascular death and is responsible for more than 3 million deaths annually worldwide.
Dawit Abraham, Kirubel Minsamo Mishore, Shambel Nigussie, Abera Jambo, Tigist Gashaw   +4 more
doaj   +1 more source

Development of a Predictive Model for Patient Compliance in Enhanced Recovery After Surgery (ERAS) Programs for Colorectal Surgery

World Journal of Surgery, EarlyView.
The newly developed compliance model will enable early identification of patients at risk of low adherence, thus supporting personalized perioperative management and improved recovery outcomes. ABSTRACT Background Enhanced recovery after surgery (ERAS) programs optimize perioperative care to reduce surgical stress and improve recovery.
Anas Taha, Bushra Mohandes, Michael Drew Honaker, Stephanie Taha‐Mehlitz, Shantanu Roy, Vincent Ochs, Otto Kollmar, Robert Rosenberg, Philippe C. Cattin   +8 more
wiley   +1 more source

Traveller's Venous Thromboembolism

Cardiovascular Surgery, 2001
K A, Parsi, M A, McGrath, R S, Lord
openaire   +3 more sources

Is Prescribing Interval Doses of Low Dose Oral Corticosteroids Still Considered Safe Treatment for Chronic Rhinosinusitis With Nasal Polyposis?

The Laryngoscope, EarlyView.
Maryam Khalifa, Brian W. Rotenberg, Leigh J Sowerby   +2 more
wiley   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source

Women's and Health Care Professionals' Experiences of Discontinuing Hormone Replacement Therapy (HRT): A Systematic Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Hormone Replacement Therapy (HRT) is used to manage menopausal symptoms, particularly vasomotor symptoms (VMS). HRT prescribing rates are rising, but most women will eventually discontinue. Objectives To explore the experiences of women stopping HRT, why women restart HRT, and the HCPs advising them. Search Strategy Embase, MEDLINE,
Sarah Bunnewell, Sabrina Keating, Jo Parsons, Martha Hickey, Sarah Hillman   +4 more
wiley   +1 more source

eGFR and venous thromboembolism

Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization ...
Shuai Yuan
core   +2 more sources

Factors Associated With Hormone Replacement Therapy Use: A Systematic Review and Meta‐Analysis

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To identify factors associated with HRT uptake among women. Design A systematic review and meta‐analysis to identify factors associated with HRT uptake. Setting Retrospective and prospective cohort studies, case–control studies and cross‐sectional studies from any country and in any language. Population The study population was women
Wema Meranda Mtika, Deborah Allen, Eve Tranter, Grace Glover, Janice Hoang, Sarah Hillman, Carol Coupland, Julia Hippisley‐Cox, Lynn Tatnell, Jennifer A. Hirst   +9 more
wiley   +1 more source

Is thromboprophylaxis effective in reducing the pulmonary thromboembolism?

ARYA Atherosclerosis, 2012
BACKGROUND: Deep vein thrombosis (DVT) is a relatively prevalent disease which causes high costs due to the required diagnostic tests, specialized treatments, and hospital admission.
Fereshteh Rajabi, Masoumeh Sadeghi, Fereshteh Karbasian, Ali Torkan   +3 more
doaj  

Hormone Replacement Therapy for Menopausal Symptoms and the Risk of Cardiometabolic Disease: Current Evidence and Future Directions

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong, Sarah Hillman, Sharon Dixon, Anupa Shah, Radha Venkatakrishnan, Jeremy W. Tomlinson   +5 more
wiley   +1 more source